American National Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $452K | Sell |
3,578
-12
| -0.3% | -$1.58K | 0.04% | 164 |
|
|
2026
Q1 | $500K | Sell |
3,590
-45
| -1% | -$6.3K | 0.05% | 153 |
|
|
2025
Q4 | $446K | Buy |
3,635
+211
| +6% | +$25.6K | 0.04% | 156 |
|
|
2025
Q3 | $380K | Buy |
3,424
+265
| +8% | +$30.1K | 0.04% | 179 |
|
|
2025
Q2 | $350K | Sell |
3,159
-46
| -1% | -$4.9K | 0.04% | 200 |
|
|
2025
Q1 | $359K | Sell |
3,205
-20
| -0.6% | -$2.06K | 0.04% | 179 |
|
|
2024
Q4 | $298K | Buy |
3,225
+433
| +16% | +$39K | 0.03% | 184 |
|
|
2024
Q3 | $234K | Sell |
2,792
-486
| -15% | -$37.1K | 0.03% | 190 |
|
|
2024
Q2 | $225K | Buy |
3,278
+519
| +19% | +$34.6K | 0.03% | 196 |
|
|
2024
Q1 | $202K | Sell |
2,759
-65
| -2% | -$5K | 0.03% | 195 |
|
|
2023
Q4 | $229K | Sell |
2,824
-155
| -5% | -$12.1K | 0.04% | 166 |
|
|
2023
Q3 | $223K | Sell |
2,979
-1,018
| -25% | -$78.3K | 0.04% | 162 |
|
|
2023
Q2 | $308K | Hold |
3,997
| – | – | 0.05% | 137 |
|
|
2023
Q1 | $332K | Sell |
3,997
-9,952
| -71% | -$824K | 0.06% | 132 |
|
|
2022
Q4 | $1.2M | Sell |
13,949
-748
| -5% | -$59.2K | 0.25% | 69 |
|
|
2022
Q3 | $907K | Sell |
14,697
-444
| -3% | -$28K | 0.22% | 75 |
|
|
2022
Q2 | $936K | Buy |
15,141
+3,581
| +31% | +$222K | 0.22% | 73 |
|
|
2022
Q1 | $687K | Buy |
11,560
+7,005
| +154% | +$448K | 0.14% | 88 |
|
|
2021
Q4 | $331K | Buy |
+4,555
| New | +$314K | 0.06% | 102 |
|
|
2020
Q2 | – | Sell |
-305
| Closed | -$23K | – | 213 |
|
|
2020
Q1 | $23K | Hold |
305
| – | – | 0.01% | 151 |
|
|
2019
Q4 | $20K | Sell |
305
-32,277
| -99% | -$2.1M | 0.01% | 160 |
|
|
2019
Q3 | $2.06M | Sell |
32,582
-12,580
| -28% | -$822K | 0.64% | 46 |
|
|
2019
Q2 | $3.05M | Sell |
45,162
-2,812
| -6% | -$185K | 0.96% | 46 |
|
|
2019
Q1 | $3.12M | Buy |
47,974
+929
| +2% | +$61.7K | 0.99% | 44 |
|
|
2018
Q4 | $2.94M | Sell |
47,045
-2,163
| -4% | -$151K | 1.07% | 41 |
|
|
2018
Q3 | $3.8M | Buy |
49,208
+8,955
| +22% | +$676K | 1.09% | 40 |
|
|
2018
Q2 | $2.85M | Sell |
40,253
-8,404
| -17% | -$593K | 0.82% | 48 |
|
|
2018
Q1 | $3.67M | Buy |
48,657
+16,090
| +49% | +$1.28M | 1.05% | 41 |
|
|
2017
Q4 | $2.33M | Buy |
32,567
+9,587
| +42% | +$728K | 0.66% | 53 |
|
|
2017
Q3 | $1.86M | Buy |
22,980
+2,630
| +13% | +$201K | 0.56% | 55 |
|
|
2017
Q2 | $1.44M | Sell |
20,350
-21,772
| -52% | -$1.45M | 0.46% | 58 |
|
|
2017
Q1 | $2.86M | Buy |
42,122
+1,763
| +4% | +$124K | 0.89% | 46 |
|
|
2016
Q4 | $2.89M | Buy |
40,359
+2,790
| +7% | +$207K | 0.94% | 48 |
|
|
2016
Q3 | $2.97M | Sell |
37,569
-1,076
| -3% | -$87.4K | 0.99% | 41 |
|
|
2016
Q2 | $3.22M | Buy |
38,645
+1,162
| +3% | +$103K | 1.18% | 35 |
|
|
2016
Q1 | $3.44M | Buy |
37,483
+4,272
| +13% | +$385K | 1.3% | 34 |
|
|
2015
Q4 | $3.36M | Buy |
33,211
+5,755
| +21% | +$599K | 1.31% | 30 |
|
|
2015
Q3 | $2.7M | Buy |
27,456
+3,694
| +16% | +$410K | 1.15% | 35 |
|
|
2015
Q2 | $2.78M | Buy |
23,762
+19,248
| +426% | +$2.1M | 1.11% | 36 |
|
|
2015
Q1 | $443K | Buy |
4,514
+1,837
| +69% | +$187K | 0.17% | 72 |
|
|
2014
Q4 | $252K | Buy |
2,677
+2,337
| +687% | +$242K | 0.1% | 84 |
|
|
2014
Q3 | $36K | Buy |
+340
| New | +$33.3K | 0.01% | 150 |
|
Other funds holding GILD
American National Bank & Trust's GILD Position: Q2 2026 in Review
American National Bank & Trust reduced its Gilead Sciences (GILD) stake by 0.33% in Q2 2026, selling an estimated $1.58K and leaving 3,578 shares worth $452K. The position accounts for 0.04% of the portfolio, ranked #164.
American National Bank & Trust first reported a position in GILD in Q3 2014 and has held it in 42 quarters since. The position peaked at $3.8M in Q3 2018. 1,018 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- American National Bank & Trust held 3,578 shares of Gilead Sciences worth $452K as of Q2 2026.
- American National Bank & Trust sold 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
- Gilead Sciences made up 0.04% of American National Bank & Trust's portfolio in Q2 2026, its #164 holding.
- American National Bank & Trust first reported a position in Gilead Sciences in Q3 2014 and has held it in 42 quarters since.
- American National Bank & Trust's Gilead Sciences position peaked at $3.8M in Q3 2018.
- 1,018 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.